Miriam Lichtner

Pubblicazioni

Titolo Pubblicato in Anno
Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA ≤50 cp/mL INFECTION 2017
Changes in inflammatory biomarkers in HCV-infected patients undergoing direct acting antiviral-containing regimens with or without interferon PLOS ONE 2017
Active HCV Replication but Not HCV or CMV Seropositive Status is associated with Incident and Prevalent Type 2 Diabetes in Persons living with HIV JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES 2017
Comparative evaluation of subtyping tools for surveillance of newly emerging HIV-1 strains JOURNAL OF CLINICAL MICROBIOLOGY 2017
Active HCV infection is associated with increased circulating levels of interferon-gamma (IFN-γ)-inducible protein-10 (IP-10), soluble CD163 and inflammatory monocytes regardless of liver fibrosis and HIV coinfection CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY 2017
Dynamics and phylogenetic relationships of HIV-1 transmitted drug resistance according to subtype in Italy over the years 2000-14 JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 2017
Hepatitis Delta Antigen (HDAg) is characterized by an extensive degree of genetic variability that correlates with elevated levels of serum HDV-RNA Journal of hepatologyJOURNAL OF HEPATOLOGY 2017
The circulation of specific vaccine-escape HBsAg mutations in HBV genotype D infected patients correlates with high viremia and affects HBsAg detection and quantification JOURNAL OF HEPATOLOGY 2017
In HBeAg-negative chronic HBV infection, HBsAg levels profoundly vary among different HBV-genotypes and can be influenced by the degree of HBsAg variability: can quantitative HBsAg truly reflect intra-hepatic HBV reservoir? JOURNAL OF HEPATOLOGY 2017
Novelties in Evaluation and Monitoring of Human Immunodeficiency Virus-1 Infection: Is Standard Virological Suppression Enough for Measuring Antiretroviral Treatment Success? AIDS REVIEWS 2017
Access and response to direct antiviral agents (DAA) in HIV-HCV co-infected patients in Italy: data from the Icona cohort PLOS ONE 2017
Awareness, discussion and non-prescribed use of HIV pre-exposure prophylaxis among persons living with HIV/AIDS in Italy: A Nationwide, cross-sectional study among patients on antiretrovirals and their treating HIV physicians BMC INFECTIOUS DISEASES 2017
Treatment of latent tuberculosis infection induces changes in multifunctional Mycobacterium tuberculosis-specific CD4(+) T cells MEDICAL MICROBIOLOGY AND IMMUNOLOGY 2016
Blood myeloid dendritic cells and slandc in antiretroviral therapy-suppressed hiv-infected patients CURRENT HIV RESEARCH 2016
Rapid decline of fasting glucose in HCV diabetic patients treated with direct-acting antiviral agents CLINICAL MICROBIOLOGY AND INFECTION 2016
Liver fibrosis in HCV monoinfected and HIV/HCV coinfected patients: dysregulation of matrix metalloproteinases (MMPs) and their tissue inhibitors TIMPs and effect of HCV protease inhibitors INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2016
Herpes virus reactivation after initiation of interferon-free antiviral agents in HIV-HCV-coinfected subjects: a new immune restoration disease? ANTIVIRAL THERAPY 2016
Abstracts of ICI 2016 International Congress of Immunology, 21-26 August 2016, Melbourne, Australia EUROPEAN JOURNAL OF IMMUNOLOGY 2016
Long-term durability of tenofovir-based antiretroviral therapy In relation to the Co-administration of other drug classes in routine clinical practice PLOS ONE 2016
Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2015 NEW MICROBIOLOGICA 2016

Progetti di Ricerca

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma